BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Intestine
,
Personalized medicine
,
Doxycycline
,
rs6983267
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fesoterodine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Review of fesoterodine.
Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms …
Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive…
Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, dou…
Fesoterodine in randomised clinical trials: an updated systematic clinical review of efficacy and sa…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
Fesoterodine on Urgency Episodes in Parkinson's Disease Population
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
Fesoterodine Flexible Dose Study
Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ